1-20 of 21
Jianqiu Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1/2 Studies of DZD8586, a Non-Covalent BBB Penetrant LYN/BTK Dual Inhibitor, in BTK Inhibitor Resistant Chronic Lymphocytic Leukemia (CLL) and Other B-Cell Non-Hodgkin Lymphoma (B-NHL)

Yuqin Song, Keshu Zhou, Hongmei Jing, Geoffrey Chong, Jianqiu Wu, Wei Liu, Zengjun Li, Ming Jiang, Mei Lan, Kaiyang Ding, Guohui CUI, Tingyu Wang, Xutao Guo, Sujun Gao, Constantine S. Tam, Haiyan Yang, Fang Zhu, Wei Yang, Jian-Qing Mi, Liping Su, Ke Fang, Ziyi Liu, Lindsey Roeker, Chan Y. Cheah, Jianyong Li, Lu-Gui Qiu
Journal: Blood
Blood (2024) 144 (Supplement 1): 3248.
https://doi.org/10.1182/blood-2024-197877
Published: 2024
Journal Articles

Real-World Study of Polatuzumab Vedotin-Based Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Chinese Cohort: Updated Results of 2-Year Follow-up

Jianqiu Wu, Fei Li, Zhi-Jun Wuxiao, Weiyan Tang, Yue Teng, Yanyan Liu, Han Chu, Zhiya Wu, Yiwen Shen, Fancong Kong, Zhihua Yao, Weilun Zhou, Jifeng Feng
Journal: Blood
Blood (2023) 142 (Supplement 1): 6265.
https://doi.org/10.1182/blood-2023-181831
Published: 2023
Journal Articles

Novel Chemotherapy-Free Initial Treatment of Rituximab Biosimilar Plus Pegylated Interferon α-2b in Pts with Untreated Advanced Indolent B-Cell Non-Hodgkin's Lymphoma: Results of the Ripple 3-Year Follow-up Study

Gao Yan, Jianqiu Wu, Yunhong Huang, Hui Zhou, Ru Feng, Fei Li, Xue-Ping Li, Xiaoxiao Wang, Bing Bai, Yu-Hua Huang, Haixia He, Liqin Ping, Yanxia He, Cheng Huang, Jibin Li, Jiaying Mao, Huiqiang Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4411.
https://doi.org/10.1182/blood-2023-186099
Published: 2023
Journal Articles

Golidocitinib in Treating Refractory or Relapsed Peripheral T- Cell Lymphoma: Full Analysis of the Multinational Pivotal Study Results (JACKPOT8)

Yuqin Song, Luis Malpica, Qingqing Cai, Weili Zhao, Keshu Zhou, Jianqiu Wu, Huilai Zhang, Kaiyang Ding, Yao Liu, Zengjun Li, Neha Mehta-Shah, Liling Zhang, Meifang Zheng, Jie Jin, Haiyan Yang, Yuerong Shuang, Dok Hyun Yoon, Sujun Gao, Wenyu Li, Zhimin Zhai, Liqun Zou, Yaming Xi, Youngil Koh, Fei Li, Miles Prince, Hui Zhou, Lie Lin, Hui Liu, Zhenfan Yang, Won Seog Kim, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 305.
https://doi.org/10.1182/blood-2023-172962
Published: 2023
Journal Articles

First Report of Phase 1 Studies of DZD8586, a BBB Penetrant LYN/BTK Dual Inhibitor, in Patients with B-Cell Non-Hodgkin Lymphoma (B-NHL)

Yuqin Song, Keshu Zhou, Hongmei Jing, Jianqiu Wu, Haiyan Yang, Yu Bai, Ke Fang, Ziyi Liu, Jun Zhu, Chan Y. Cheah
Journal: Blood
Blood (2023) 142 (Supplement 1): 4465.
https://doi.org/10.1182/blood-2023-185270
Published: 2023
Journal Articles

XPO1 Inhibitor (ATG-010) Plus GemOx Regimen for Heavily Pretreated Patients with Relapsed or Refractory (R/R) T and NK-Cell Lymphoma：Updates of the Phase Ib Touch Study

Huiqiang Huang, Yan Gao, Huilai Zhang, Keshu Zhou, Jianqiu Wu, Zhen Cai, Hongmei Jing, LEI Fan, Sai Lou, Yizhou Fei, Aihua Wang, Kevin Lynch
Journal: Blood
Blood (2022) 140 (Supplement 1): 6554–6555.
https://doi.org/10.1182/blood-2022-165797
Published: 2022
Journal Articles

Efficacy and Safety of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma in China

Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Jianqiu Wu, Alex Tian, Tony Huang, Zisong Zhou, Meilin Ma, Su Yang, Yun Qin, Jun Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10329–10331.
https://doi.org/10.1182/blood-2022-162985
Published: 2022
Journal Articles

Primary Clinical Response of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma (r/r FL) in China

Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Jianqiu Wu, Su Yang, Pian Zhang, Meilin Ma, Zisong Zhou, Hongxia Zheng, Jun Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2434.
https://doi.org/10.1182/blood-2021-150085
Published: 2021
Journal Articles

XPO1 Inhibitor (ATG-010) Plus Chemotherapy per Investigator's Choice for Heavily Pretreated Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Extranodal NK/T-Cell Lymphoma (ENKTL)：Preliminary Results from a Multicenter, Single-Arm, Phase Ib Study (TOUCH Trial)

Huiqiang Huang, Yan Gao, Huilai Zhang, Keshu Zhou, Jianqiu Wu, Zhen Cai, Hongmei Jing, Lei Fan, Sai Lou, Yizhou Fei, Aihua Wang, Kevin Lynch
Journal: Blood
Blood (2021) 138 (Supplement 1): 2452.
https://doi.org/10.1182/blood-2021-147100
Published: 2021
Journal Articles

Relmacabtagene Autoleucel CD19 CART Therapy for Adults with Heavily-Pretreated Relapsed/Refractory Large B-Cell Lymphoma in China

Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Daobin Zhou, Zhao Wang, Mingzhi Zhang, Jianqiu Wu, Hui Liu, Pian Zhang, Su Yang, Zisong Zhou, Hongxia Zheng, Jun Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3557.
https://doi.org/10.1182/blood-2021-148358
Published: 2021
Journal Articles

Rituximab Biosimilar Combined with Pegylated Interferon α-2b in Patients with Untreated Advanced Indolent B-Cell Non-Hodgkin's Lymphoma: Preliminary Results from a Multicenter, Single-Arm, Phase II Study

Gao Yan, Jianqiu Wu, Yunhong Huang, Hui Zhou, Ru Feng, Li Fei, Xiaoxiao Wang, Bing Bai, Yuhua Huang, Haixia He, Liqin Ping, Yanxia He, Cheng Huang, Jibin Li, Jiaying Mao, Huiqiang Huang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1359.
https://doi.org/10.1182/blood-2021-152018
Published: 2021
Journal Articles

Clinical Response of CD19 CAR-T Cells (relmacabtagene autoleucel, relma-cel) in Adults with Heavily-Pre-Treated Relapsed/Refractory (r/r) Large B-Cell Lymphoma in China

Jun Zhu, MD, Zhitao Ying, MD, Yuqin Song, MD PhD, Haiyan Yang, MD PhD, Ye Guo, MD, Wenyu Li, PhD, Dehui Zou, MD, Daobin Zhou, MD PhD, Zhao Wang, MD, Mingzhi Zhang, MD, Jianqiu Wu, MD, Hui Liu, MD, Pian Zhang, Su Yang, Zisong Zhou, Hongxia Zheng, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-136038
Published: 2020
Journal Articles

A Multicenter Real-Life Study of Polatuzumab Vedotin Combined with Immunochemotherapy in Patients with R/R DLBCL: Preliminary Data on Efficacy and Safety in Chinese Cohort

Jianqiu Wu, Yanyan Liu, Li Fei, Zhi-Jun Wuxiao, Fancong Kong, Zhihua Yao, Weilun Zhou, Jifeng Feng
Journal: Blood
Blood (2020) 136 (Supplement 1): 50–51.
https://doi.org/10.1182/blood-2020-142553
Published: 2020
Journal Articles

Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study

Jianqiu Wu, Yongping Song, Liping Su, Mingzhi Zhang, Wei Li, Yu Hu, MD PhD, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, MD, Wei Wang, Jiewen Peng, Xiaolin Li, Xuenong Ouyang, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, PhD, Zimin Sun, Hai Bai, Tongjian Cui, Jifeng Feng
Journal: Blood
Blood (2017) 130 (Supplement 1): 5167.
https://doi.org/10.1182/blood.V130.Suppl_1.5167.5167
Published: 2017
Journal Articles

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Jianqiu Wu, Yongping Song, Liping Su, Mingzhi Zhang, Wei Li, Yu Hu, MD PhD, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, MD, Wei Wang, Jiewen Peng, Xuenong Ouyang, Xiaolin Li, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, PhD, Zimin Sun, Hai Bai, Tongjian Cui, Jifeng Feng
Journal: Blood
Blood (2017) 130 (Supplement 1): 5213.
https://doi.org/10.1182/blood.V130.Suppl_1.5213.5213
Published: 2017
Journal Articles

Three-Year Follow-up on Safety and Effectiveness of Rituximab Plus Chemotherapy As First-Line Treatment of Diffuse Large B-Cell Lymphoma

Jifeng Feng, Jianqiu Wu, Yongping Song, Liping Su, Mingzhi Zhang, Wei Li, Yu Hu, MD PhD, Xiaohong Zhang, Yuhuan Gao, Zuoxing Niu, Ru Feng, MD, Wei Wang, Jiewen Peng, Xiaolin Li, Xuenong Ouyang, Changping Wu, Weijing Zhang, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, PhD, Zimin Sun, Hai Bai, Tongjian Cui
Journal: Blood
Blood (2017) 130 (Supplement 1): 5208.
https://doi.org/10.1182/blood.V130.Suppl_1.5208.5208
Published: 2017
Journal Articles

A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma

Jifeng Feng, MD, Jianqiu Wu, MD, Yongping Song, Liping Su, Mingzhi Zhang, MD, Wei Li, Yu Hu, Xiaohong Zhang, MD, Yuhuan Gao, Ru Feng, MD, Wei Wang, MD, Zuoxing Niu, Jiewen Peng, Xiaolin Li, Xuenong Ouyang, Changing Wu, Weijing Zhang, MD, Yun Zeng, Zhen Xiao, Yingmin Liang, Yongzhi Zhuang, Jishi Wang, Zimin Sun, PharmD, Hai Bai, Tongjian Cui
Journal: Blood
Blood (2014) 124 (21): 5475.
https://doi.org/10.1182/blood.V124.21.5475.5475
Published: 2014
Journal Articles

Vascular Gas6 contributes to thrombogenesis and promotes tissue factor up-regulation after vessel injury in mice

Richard S. Robins, Catherine A. Lemarié, Sandrine Laurance, Meghedi N. Aghourian, Jianqiu Wu, Mark D. Blostein
Journal: Blood
Blood (2013) 121 (4): 692–699.
https://doi.org/10.1182/blood-2012-05-433730
Published: 2013
Includes: Supplemental data
Journal Articles

TLR3 Activation Is Involved in Venous Thrombosis Development

Catherine A Lemarie, Angela Le, Meghedi Aghourian, Jianqiu Wu, Mark D Blostein
Journal: Blood
Blood (2012) 120 (21): 3309.
https://doi.org/10.1182/blood.V120.21.3309.3309
Published: 2012
Journal Articles

ENDOTHELIAL GAS6 Contributes to Thrombogenesis and Promotes TISSUE FACTOR Upregulation DURING Vessel Injury

Richard Robins, Catherine A Lemarie, Jianqiu Wu, Mark Blostein
Journal: Blood
Blood (2011) 118 (21): 702.
https://doi.org/10.1182/blood.V118.21.702.702
Published: 2011